HM4: The evolving clinical trial landscape


The European Clinical Trials Regulation (EU CTR) took effect on 31 January 2022. Since then, authorities, sites and sponsors have had to embrace the new Regulation to begin to successfully run clinical trials across the EU. Since 31 January 2023, all clinical trial applications (CTAs) must be submitted through the Clinical Trials Information System (CTIS) and since then, all stakeholders have been dealing with its updates, challenges, revisions and simplifications. In this panel we were fortunate to be able to hear from the different perspectives: EMA, European Commission, industry and consultancy.

How to read this journal article 

Thank you for visiting Regulatory Rapporteur. Journal articles are restricted to registered users and TOPRA members.

Already a member or have an account? Sign in.


Free access to selected content

Register now to continue to access industry news, editorials and podcasts plus one member-only journal article each month.

  • Create your own library to save your favourite content.
Create a free account

2. Members login

Already a TOPRA member?

Log-in now using your MyTOPRA credentials, for unlimited access to all Regulatory Rapporteur journal articles, the online archive and latest industry news and podcasts.



Special offer on
TOPRA membership

Join TOPRA today and get membership until the end of 2025 for the exclusive rate of £290.

In addition to unlimited access to Regulatory Rapporteur content, as a TOPRA member you will also be able to enjoy a wide range of benefits including career boosting resources, savings on our events and training, and access to our regional networks and special interest groups.

This offer ends 31 July 2024

Become a member